GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.15G019600	P07063	Suffruticoside E	3	2.37129702091563e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P10528	Etoperidone	3	3.20076271826612e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P21894	N-[4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide	3	4.34883438504328e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P26425	Cinnacassiol	3	1.17408871090776e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P27877	Pinocembrin 7-O-neohesperidoside 3'''-O-acetate	3	7.31014275449551e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P29609	3,6-Dimethyl-1,4-dioxane-2,5-dione	3	5.41142043737506e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P34700	Phaseoloidin	3	6.50790084017044e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P37609	(25R)-spirost-6-ene-3beta-ol-5alpha,8alpha-epidioxy-3-O-alpha-l-rhamnopyranosyl-(1-4)-[alpha-l-rhamnopyranosyl-(1-2)- beta-D-glucopyranoside	3	6.03837297033845e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P41593		3	1.73618005647164e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P00695	4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9A-triaza-benzo[CD]azulene-1-thione	2	3.20339529889883e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P01171		2	5.40341887641172e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P01910		2	3.1342257737308e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P02741	Parbendazole	2	4.81778460397437e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P09793	Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)-	2	1.03476771087094e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P19817		2	6.78139313339709e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P21831	4,5-Dihydro-4-((1-piperazinyl)acetyl)-7-(3-(trifluoromethyl)phenyl)pyrazolo(1,5-a)pyrimidine-3-carbonitrile	2	1.86731537177666e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P24506	O-Sulfotyrosine	2	3.68959365081355e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P24832	Stercobilin	2	1.65520923440984e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P26326		2	3.41424888748713e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P30741	3-(Allyloxy)estra-1,3,5(10)-triene-16beta,17beta-diol	2	5.75452535624868e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P30783	CDP-DG(18:1(12Z)-2OH(9,10)/a-17:0)	2	7.33105637475839e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P31378	Caucasicoside B	2	2.38249073655359e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P41054	CDP-DG(18:2(9Z,11E)+=O(13)/18:1(11Z))	2	4.71986355537009e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P46320	Candoxatril	2	3.2232518292927e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P47621	2-Aminobiphenyl	2	1.67065211504392e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P50455	Carrageenan, potassium salt of	2	4.44838758791542e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P52212	2-Chloro-N-icosa-5,8,11,14-tetraenylacetamide	2	8.37822807798621e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G019600	P53176		2	8.76511964537892e-12	overlap	1e-10	<	Wm82.a2.v1